Skip to main content

Blog

Watch: Dyne Therapeutics — Advancing DYNE-251, an Investigational Medicine for DMD (Webinar Recording)

...

REGENXBIO Announces Completion of Enrollment in Cohort 2 and Additional Positive Interim Data in AFFINITY DUCHENNE® Trial

...

Duchenne Newborn Screening Bill Passes Arizona Senate

...

Watch: Navigating Steroid Choices – Understanding the Process, Pathways, and Policies (Webinar Recording)

...

PPMD 2023 Duchenne Early Care Meeting Report Published: Enhancing Support in Early Diagnosis

...

Sarepta Therapeutics Reports Positive Data from Part B of MOMENTUM Study of SRP-5051

...

Duchenne Added to Minnesota’s Newborn Screening Panel

...

CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) in Europe

...

Astellas Releases Results of Discontinued Phase 1b Study of ASP0367

...

PPMD Hosts 2024 Duchenne Healthcare Professionals Summit

...